Thymosin Alpha-1
- •what is Thymosin Alpha-1
- •Zadaxin
- •Thymosin Alpha-1 immune
- •Thymosin Alpha-1 hepatitis
- •Thymosin Alpha-1 cancer
- •Thymosin Alpha-1 COVID
- Thymosin Alpha-1(TA1)· Immune System & Inflammation
- Your thymus gland is the training ground for your immune system — but it shrinks dramatically with age. Thymosin Alpha-1 is one of the active peptides the thymus naturally produces, supporting T-cell maturation and immune balance. The synthetic version has decades of clinical use abroad for chronic infections, cancer adjunct therapy, and as a vaccine booster. It has a strong safety record and is one of the few research peptides with broad international clinical approval.
What is it?
Thymosin Alpha-1 (Tα1) is a 28-amino-acid peptide naturally produced by the thymus gland, first isolated from bovine thymic extracts in the 1970s. The synthetic version is marketed as Zadaxin and is approved in over 35 countries (not the US) for hepatitis B, hepatitis C, certain cancers, and as a vaccine adjuvant. It is one of the most extensively studied immune-modulating peptides in the world. Research-grade thymosin alpha-1 is sold for laboratory use.
In plain English
Your thymus gland is the training ground for your immune system — but it shrinks dramatically with age. Thymosin Alpha-1 is one of the active peptides the thymus naturally produces, supporting T-cell maturation and immune balance. The synthetic version has decades of clinical use abroad for chronic infections, cancer adjunct therapy, and as a vaccine booster. It has a strong safety record and is one of the few research peptides with broad international clinical approval.
How it works
Thymosin Alpha-1 binds TLR9 and other pattern recognition receptors on dendritic cells, supporting Th1 immune responses, T-cell maturation, and immune balance under stress. It supports the development of cytotoxic T-cells against viral and tumor antigens, improves NK cell function, and helps modulate inflammation in autoimmune contexts.
What researchers study
- •Hepatitis B and C (approved indications abroad)
- •Sepsis and severe infection support
- •Cancer immunotherapy adjunct
- •COVID-19 immune support research
- •Chronic fatigue and immune dysregulation
- •Vaccine adjuvant research
What the internet talks about
Thymosin Alpha-1 is widely discussed in immune-focused biohacker and chronic-illness forums. It is a staple in Lyme, chronic viral, and post-COVID protocols, often combined with VIP and BPC-157. Users emphasize its decades-long international safety record and its position as one of the most clinically validated research peptides.
Bro-science translation
“The thymus's own immune-balancing peptide.”
Commonly compared to
Common stack discussions
Most commonly combined with BPC-157 in immune/inflammation protocols, with VIP in CIRS protocols, and with thymalin for combined thymic-peptide approaches.
Related peptides
Related categories
Frequently asked questions
Quick summary
Thymosin Alpha-1 (Zadaxin) is a 28-amino-acid thymic peptide approved in 35+ countries for hepatitis B, hepatitis C, and cancer adjunct therapy. It supports T-cell maturation and immune balance.